NCT06928844View on ClinicalTrials.gov

Role of Low Dose Injectable Progesterone in Triggering Ovulation

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Low DoseProgesteroneTriggering Ovulation
Interventions
DRUG

Progesterone

Women will receive low dose progesterone 5 mg intramuscularly as a study group. (Letrozole 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).

DRUG

Placebo

Women will receive placebo as a control group. (Placebo 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).

Trial Locations (1)

Unknown

RECRUITING

Teaching Hospitals and Institutes, Cairo

All Listed Sponsors
lead

The General Authority for Teaching Hospitals and Institutes

NETWORK